Volume 14, Issue 1 ( March 2022 2022)
Iranian Journal of Blood and Cancer 2022, 14(1): 1-5 |
Back to browse issues page
1- Bushehr University of Medical Sciences, Bushehr, Iran
2- Bushehr University of Medical Science, Shiraz, Iran , mbordbar53@gmail.com
2- Bushehr University of Medical Science, Shiraz, Iran , mbordbar53@gmail.com
Abstract: (1807 Views)
Introduction: The objective of this study is to determine the major causes of early death in acute lymphoblastic leukemia (ALL).
Methods: The following databases including PubMed, EMBASE, Science Direct and Google Scholar were searched for following terms: “acute lymphoblastic leukemia”, “early mortality”, “early death “ and “death in induction phase “. Inclusion criteria were all studies about the etiologies of early mortality in children with acute lymphoblastic leukemia. Early death means death occurs within 30 days of starting induction chemotherapy.
Results: In total, 12 studies fulfilled inclusion criteria.7561 children under 18 years of age were studied in this review. Of these, 354 patients died during the induction phase of therapy. The early mortality rate was 4.6%±4.8. The most common cause of early death was an infection (52.5%), which was mainly bacterial. The second leading cause was bleeding (15%), and tumor lysis syndrome (4%) was the third most common cause. The other causes were septic shock (2%), hyperleukocytosis (2%), encephalopathy (1.7%), cardiomyopathy (1.7%), chemotherapy-related toxicity (1.2%), and thrombotic events (0.6%).
Conclusion: It is needed to advance supportive care to prevent infection by starting Intravenous immunoglobulin for infant and prophylaxis against Pneumocystis jiroveci with trimethoprim/sulfamethoxazole in neutropenic patients during induction, and bleeding by transfusion support.
: Review Article |
Subject:
Pediatric Hematology & Oncology
Received: 2020/07/24 | Accepted: 2022/03/21 | Published: 2022/04/30
Received: 2020/07/24 | Accepted: 2022/03/21 | Published: 2022/04/30
References
1. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015;373(16):1541-52. 10.1056/NEJMra1400972. [DOI:10.1056/NEJMra1400972]
2. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-78. [DOI:10.1056/NEJMra052603]
3. Slats AM, Egeler RM, van der Does-van den Berg A, Korbijn C, Hählen K, Kamps WA, et al. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia. 2005;19(4):537-44. [DOI:10.1038/sj.leu.2403665]
4. Dini G, Bartolini M, Massimo L, Ceci A, Paolucci G, Calculli G, et al. Early deaths in acute lymphoblastic leukemia (ALL): results of the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). Med Pediatr Oncol. 1984;12(3):189-93. [DOI:10.1002/mpo.2950120309]
5. Rubnitz JE, Lensing S, Zhou Y, Sandlund JT, Razzouk BI, Ribeiro RC, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer. 2004;101(7):1677-84. [DOI:10.1002/cncr.20532]
6. Hurwitz CA, Silverman LB, Schorin MA, Clavell LA, Dalton VK, Glick KM, et al. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer. 2000;88(8):1964-9.
https://doi.org/10.1002/(SICI)1097-0142(20000415)88:8<1964::AID-CNCR27>3.0.CO;2-1 [DOI:10.1002/(SICI)1097-0142(20000415)88:83.0.CO;2-1]
7. Liang DC, Hung IJ, Yang CP, Lin KH, Chen JS, Hsiao TC, et al. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy forchildhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group. Leukemia.
8. Salzer W, Dinndorf P, Dreyer Z, Hilden J, Reaman GH. Analysis of infectious complications in infants with acute lymphoblastic leukemia treated on the Children's Cancer Group Protocol 1953: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2009;31(6):398-405. [DOI:10.1097/MPH.0b013e3181a6dec0]
9. Salzer WL, Jones TL, Devidas M, Dreyer ZE, Gore L, Winick NJ, et al. Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015;62(3):414-8. [DOI:10.1002/pbc.25311]
10. Martín-Trejo JA, Núñez-Enríquez JC, Fajardo-Gutiérrez A, Medina-Sansón A, Flores-Lujano J, JiménezHernández E, et al. Early mortality in children with acute lymphoblastic leukemia in a developing country: the role of malnutrition at diagnosis. A multicenter cohort MIGICCL study. Leuk Lymphoma. 2017;58(4):898-908. [DOI:10.1080/10428194.2016.1219904]
11. Gupta S, Antillon FA, Bonilla M, Fu L, Howard SC, Ribeiro RC, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer. 2011;117(20):4788-95. [DOI:10.1002/cncr.26107]
12. Salzer WL, Jones TL, Devidas M, Hilden JM, Winick N, Hunger S, et al. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407. Pediatr Blood Cancer. 2012;59(5):834-9. [DOI:10.1002/pbc.24132]
13. Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India. J Pediatr Hematol Oncol. 2010;32(5):366-9. [DOI:10.1097/MPH.0b013e3181e0d036]
14. Jaing TH, Lin JL, Lin YP, Yang SH, Lin JJ, Hsia SH. Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2009;31(12):955-6. [DOI:10.1097/MPH.0b013e3181b8beb1]
15. Hvizdala E, Berry DH, Chen T, Dyment PG, Kim TH, Steuber CP, et al. Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Med Pediatr Oncol. 1984;12(3):173-7. [DOI:10.1002/mpo.2950120306]
16. Bergmann K, Hasle H, Asdahl P, Handrup MM, Wehner PS, Rosthøj S, et al. Central Venous Catheters and Bloodstream Infection During Induction Therapy in Children With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016;38(3):e82-7. [DOI:10.1097/MPH.0000000000000519]
17. Prucker C, Attarbaschi A, Peters C, Dworzak MN, Pötschger U, Urban C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian BerlinFrankfurt-Münster study group. Leukemia. 2009;23(7):1264-9. [DOI:10.1038/leu.2009.12]
18. Cheng S, Pole JD, Sung L. Early deaths in pediatric acute leukemia: a population-based study. Leuk Lymphoma. 2014;55(7):1518-22. [DOI:10.3109/10428194.2013.850685]
19. Mushtaq N, Fadoo Z, Naqvi A. Childhood acute lymphoblastic leukaemia: experience from a single tertiary care facility of Pakistan. J Pak Med Assoc. 2013;63(11):1399-404.
20. . Jiménez-Hernández E, Jaimes-Reyes EZ, ArellanoGalindo J, García-Jiménez X, Tiznado-García HM, Dueñas-González MT, et al. Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01. Biomed Res Int. 2015;2015:576950. [DOI:10.1155/2015/576950]
21. Wheeler K, Chessells JM, Bailey CC, Richards SM. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X. Arch Dis Child. 1996;74(2):101-7. [DOI:10.1136/adc.74.2.101]
22. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987;5(2):202-7. [DOI:10.1200/JCO.1987.5.2.202]
23. Seif AE, Fisher BT, Li Y, Torp K, Rheam DP, Huang YS, et al. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(5):846-52. [DOI:10.1002/pbc.24855]
24. Lehrnbecher T, Robinson PD, Fisher BT, Castagnola E, Groll AH, Steinbach WJ, et al. Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and MetaAnalysis. Clin Infect Dis. 2016;63(10):1340-8. [DOI:10.1093/cid/ciw592]
25. O'Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056-61. [DOI:10.1182/blood-2014-03-560847]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |